Bill > HB2912

This bill requires insurance providers in West Virginia to provide coverage for GLP-1 class medications when a patient has a valid prescription. GLP-1 (glucagon-like peptide-1) medications are a class of drugs primarily used to treat type 2 diabetes and obesity by helping to regulate blood sugar and appetite. The bill amends existing insurance regulations to mandate that insurers cover these medications, which can include popular weight loss drugs like Ozempic, Wegovy, and Mounjaro. By requiring insurance coverage, the bill aims to improve access to these medications for patients who may need them for managing diabetes or obesity, potentially reducing healthcare costs associated with these chronic conditions in the long term. The legislation specifically states that coverage must be provided "under this article" and is contingent upon the patient having a legitimate prescription from a healthcare provider.

Health and Social Services

http://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=2912&year=2025&sessiontype=RS&btype=bill